Evaluation of Long-Term Immunogenicity in Subjects Boosted With a TBE Vaccine for Adults

Novartis

Status and phase: Completed; Phase 4

Conditions: Encephalitis, Tick-Borne

Treatments: Biological: Tick-Borne Encephalitis vaccine

Study type: Interventional

Funder types: Industry

Identifiers

NCT00311493

V48P2E3

498

Details and patient eligibility

About

The purpose of this study it is to evalutate the persistence of antibodies after a booster immunisation with a TBE vaccine for adults

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Healthy volunteers of both sexes aged >18 who participated in another study on TBE vaccination

Exclusion criteria

• Subjects with any condition, in the opinion of the Investigator, might interfere with the evaluation of the study objectives.

Trial design

Primary purpose: Prevention

Allocation: Randomized

Interventional model: Factorial Assignment

Masking: None (Open label)